Autism spectrum disorders (ASD) are a group of relatively common neurodevelopmental disorders affecting between 2 and 6 children per 1000. The aetiology of autism is unknown with both environmental and genetic factors considered to play key roles. Different research groups have described various immune abnormalities, including increased levels of inflammatory mediators and the presence of autoimmune phenomena. The intestinal microbiota has marked influences on the intestinal and peripheral host's immunity and differences between ASD and healthy children's microbiota have been reported. Tryptophan (TRP) is an essential amino acid that is preferentially acquired from the diet and is the precursor of a wide range of biologically active substances such as serotonin, melatonin and kynurenine, the role of this metabolic pathway in autism deserves more detailed analysis.
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NF-kb is a transcriptional factor that intervenes in the synthesis of the proinflammatory cytokines by cells in the innate immune system and intestinal enterocytes. On the other hand, IgA belongs to the acquired immunity. Differences in the microbial composition of different systems may catabolise TRP using different pathways. The response of NF-kb and IgA1 to TRP metabolites was considered weak. However, there was a significant difference in IgA expression which was up-regulated in the systems inoculated with ASD faecal microbiota. Flow rate did not affect gene expression. IgA response was related to Clostridium histolyticum. Interestingly, this group of gut bacteria was significantly higher in ASD children. Further investigation is necessary to elucidate the relationship between immunological findings, microbiota and behaviour in autism.
